SK

Sanjay Koul

Director Director DIN 09788071
DIN 09788071 First appointment Oct 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2022
Shareholding value •••• Premium profile

About Sanjay Koul

Data last updated:

Sanjay Koul was a Director at Upakarma Ayurveda Private Limited (2022–2025) and Ceo at Mankind Life Sciences Private Limited (2022–2025). The companies operate in Healthcare and Pharma.

DIN 09788071
Primary Designation Director
Industry Healthcare
First Appointment 01 Oct 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Upakarma Ayurveda Private Limited U36999DL2017PTC326510
Director11 Nov 20222017₹13.17 Cr (FY 2025)Active
Ceo01 Oct 20222020₹90.12 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Upakarma Ayurveda Private Limited
Mankind Life Sciences Private Limited
Premium access

Shareholding and investment profile for Sanjay Koul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Koul

Sanjay Koul was first appointed on 01 Oct 2022 as Ceo at Mankind Life Sciences Private Limited.

Sanjay Koul held 2 earlier board appointments: Upakarma Ayurveda Private Limited (Director, 11 Nov 2022 to 01 Aug 2025); Mankind Life Sciences Private Limited (Ceo, 01 Oct 2022 to 01 Aug 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available